Analysis of causation in connection with off-label marketing
In State of New Mexico, ex rel. Hector H. Balderas, Attorney General v. Solvay Pharmaceuticals, Inc., Eric Gaier served as testifying expert regarding causation in connection with alleged off-label marketing of the testosterone replacement therapy drug AndroGel® and challenged non-branded low testosterone disease state awareness campaigns that allegedly violated New Mexico’s Unfair Practices Act and False Advertising Act. The matter settled before trial.